Tag: Rahul Koul
“Latest medical technology bill opens a suitable channel for adopting new technologies”
Exclusive interview with Chandra Ganjoo, Group Chief Executive Officer, Trivitron Healthcare
“We expect a sea change in Indian biotech landscape”
Exclusive interaction with Aditya Sharma, Head-Bioprocessing Business, Merck Life Science India
“Public perception about clinical trials has witnessed a drastic change”
This edition of Chat with BioVoice features Ajay Tandon, Managing Director, Veeda Clinical Research Limited
BioVoice eMagazine December 2022 Issue 3 Volume 3
Click to Read: BioVoice eMagazine December 2022 Issue 3 Volume 3
The Cover Story in the current edition focuses on India's strong biotech R&D segment...
FACE TO FACE: Amol Naikawadi, Joint Managing Director, Indus Health Plus
In a highly informative conversation with Rahul Koul, Chief Editor, BioVoice News, the Joint Managing Director of Indus Health Plus, Amol Naikawadi shared his...
BioVoice eMagazine November 2022 Issue 2 Volume 3
Click to Read: BioVoice News November 2022 Issue 2 Volume 3
The Cover Story in the current edition turns its spotlight on the genetically modified mustard. Its recent...
FACE TO FACE: Mahesh Pratapneni, Co-founder & Group CEO, MedGenome
In a highly informative conversation with Rahul Koul, Chief Editor, BioVoice News, the Co-founder & Group CEO of MedGenome, Mahesh Pratapneni, demystifies the concept of...
“We want to be at the forefront of genetic diagnostic revolution”
Subhamoy Dastidar, Co-Founder and Director, Lilac Insights believes that there has been a growing acceptance of genetic testing in India
FACE to FACE: Abhishek Mohan, Founder & CEO, HempStreet
Click to watch the full interview
Abhishek Mohan, Founder and Chief Executive Officer, HempStreet has been in the startup space for over 15 years now....
“India continues to remain a key destination for clinical trials”
Jinu Jose, Vice President, Head – Sales and Clinical Operations, R&D Solutions, IQVIA India shared his views on the company's current operations, market scenario and future outlook